Koligo Therapeutics Limited operates as a biotechnology company. The Company focuses on the development and commercialization of a range of cell therapy, three-dimensional bioprinted tissue and other regenerative medicine products for serious medical needs. Koligo Therapeutics serves patients in the United States and Australia.